COMPASS Pathways plc (CMPS)
NASDAQ: CMPS · Real-Time Price · USD
7.35
+0.04 (0.55%)
At close: Jan 16, 2026, 4:00 PM EST
7.30
-0.05 (-0.68%)
After-hours: Jan 16, 2026, 7:59 PM EST
COMPASS Pathways Market Cap
COMPASS Pathways has a market cap or net worth of $705.73 million as of January 16, 2026. Its market cap has increased by 172.87% in one year.
Market Cap
705.73M
Enterprise Value
554.97M
1-Year Change
172.87%
Ranking
Category
Stock Price
$7.35
Market Cap Chart
Since the IPO on September 18, 2020, COMPASS Pathways's market cap has increased from $568.58M to $705.73M, an increase of 24.12%. That is a compound annual growth rate of 4.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 705.73M | 6.52% |
| Dec 31, 2025 | 662.52M | 156.16% |
| Dec 31, 2024 | 258.63M | -52.25% |
| Dec 29, 2023 | 541.59M | 58.41% |
| Dec 30, 2022 | 341.89M | -62.93% |
| Dec 31, 2021 | 922.26M | -46.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 924.90B |
| Johnson & Johnson | 529.01B |
| AbbVie | 383.08B |
| UnitedHealth Group | 307.04B |
| AstraZeneca | 291.28B |
| Merck & Co. | 275.43B |
| Novartis AG | 273.64B |
| Novo Nordisk | 252.12B |